Development of pH-Sensitive Nanoparticle Incorporated into Dissolving Microarray Patch for Selective Delivery of Methotrexate
CONCLUSION: The developed SNP-DMAP-MTX has been proven to deliver MTX transdermal and selectively at the RA site, potentially avoiding conventional MTX side effects and enhancing the effectiveness of RA therapy.PMID:38538953 | DOI:10.1208/s12249-024-02777-y
Source: AAPS PharmSciTech - Category: Drugs & Pharmacology Authors: Nur Qadri Febrianti Anugerah Yaumil Ramadhani Aziz Muhamad Gilang Ramadhan Tunggeng Indianty Dwi Ramadhany Nur Syafika Sumayya Binti Abd Azis Yulia Yusrini Djabir Rangga Meidianto Asri Andi Dian Permana Source Type: research
More News: Arthritis | Autoimmune Disease | Chemistry | Drugs & Pharmacology | Methotrexate | Nanotechnology | Polyethylene Glycol | Rheumatoid Arthritis | Rheumatology | Study | Toxicology